FDA Inspection 1089783 — Novaprobe Inc.
The FDA completed an inspection of Novaprobe Inc. on April 15, 2019 in Lansdale, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 15, 2019
- Fiscal Year
- 2019
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Lansdale, PA (United States)